🔗 Permalink

Inventor profile of:

DAVID A. CLARK

City:

Burlington

Country:

Canada

Published Applications:

Last publication date:

2011-08-25

Top Assignees for applications by DAVID A. CLARK

The entities that hold a legal rights for patent applications filed by inventor CLARK DAVID A.:

Trillium Therapeutics Inc. 8 Toronto, Ontario, Canada
TRILLIUM THERAPEUTICS INC. 5 Toronto, Canada
TRILLIUM THERAPEUTICS INC. 2 Toronto, ON Canada

Recent patent applications by CLARK DAVID A.

DAVID A. CLARK from Burlington, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-08-25

US20110206668A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING IMMUNITY

#2 | 2011-06-02

US20110129466A1

Chemistry; metallurgy

Methods of treating cancer by administering antibodies to CD200

#3 | 2009-09-17

US20090232825A1

Chemistry; metallurgy

Methods and compositions for modulating immunity

#4 | 2009-02-26

US20090053222A1

Chemistry; metallurgy

Methods of treating cancer by administering antibodies to CD200

#5 | 2007-11-08

US20070258977A1

Chemistry; metallurgy

Methods of treating cancer by administering antibodies to CD200

#6 | 2007-11-06

US10221154

MD-1 inhibitors as immune suppressants

#7 | 2007-08-23

US20070197443A1

Chemistry; metallurgy

Methods and compositions for modulating immunity

#8 | 2007-06-07

US20070128198A1

Chemistry; metallurgy

COMPOSITIONS COMPRISING ANTIBODIES TO HUMAN FGL2

#9 | 2006-02-09

US20060029607A1

Chemistry; metallurgy

Methods and compositions for modulating tumor growth

#10 | 2005-10-18

US9917278

Methods of inhibiting immune response suppression by administering antibodies to OX-2

#11 | 2005-08-04

US20050169913A1

Chemistry; metallurgy

Compositions comprising antibodies to human FgI2

#12 | 2005-03-03

US20050048069A1

Chemistry; metallurgy

Methods of treating allergy by administering a CD200 protein

InventorID:

3432114 ⎘